Home
Browse
Browse By MHC Allele
Browse By Source Organism
Browse By 3D Structure
Search
B Cell Search
T Cell Search
MHC Binding Search
MHC Ligand Elution Search
Epitope Search
Identifier Search
Tools
T Cell Epitope Prediction
B Cell Epitope Prediction
Epitope Analysis Tools
Support
Solutions Center
Provide Feedback
Help Request
Data Field Descriptions
More IEDB
Acknowledgements
Citing the IEDB
Database Export
Documents
IEDB Ontology
Links
Patent List
Publications
Terms of Use
T Cell Search
Reference
Author
Title
Reference Details
Reference ID
Abstract
Affiliations
Date (Year)
Equal To
After
Before
Between
And
Reference Type
Journal Article
Submission
Any
Article Fields
Article PubMed ID
Journal Name
Journal Volume
Article Pages
Journal ISSN
Article Chemical List
Article MeSH List
Article Comments
Submission Fields
Submission ID
Submission Keywords
Submitter Name
Enter Sequence
Apply
Clear
Epitope
Epitope ID
Type
Source Molecule
Source Organism
Object Type
Molecule Name
Discontinuous Residues
Peptide Sequence
Exact Matches
Substring
Blast - 90%
Blast - 80%
Blast - 70%
Modified Residue(s)
Modification(s)
1,2-dimethylpropylamine
2-aminoisobutiric acid
4-azidobenzoic acid (ABA)
Acetylation|ACET
Amidation|AMID
Biotin|BIOT
Citrullination|CITR
Cysteinylation
D-aminoacid
Deamidation followed by a methylation|DEAME
Deamidation|DEAM
Fluorenylmethyloxycarbonyl
Formylation|FORM
Galactosylation
Glucosylation (Glycation)|GLUC
Glycosylation
I/L uncertainty
iodo-4-azidosalicylic acid (IASA)
Hydroxylation
Hydroxylation and Galactosylation
Hydroxylation, Glucosylation, and Galactosylation
Main chain modification
Methylation|METH
Myristoylation|MYRI
N-acetylation
Nitration
Norleucine substitution
Oxidation
Palmitoylation|PALM
Phosphorylation|PHOS
Pyrrolidone carboxylic acid (Glu)|PYRE
Reduction
S-acetylmercaptoacetyl
Stereoisomer
Chain 1 Name
Molecule Accession
Source Organism
Modified Residue(s)
Modification(s)
1,2-dimethylpropylamine
2-aminoisobutiric acid
4-azidobenzoic acid (ABA)
Acetylation|ACET
Amidation|AMID
Biotin|BIOT
Citrullination|CITR
Cysteinylation
D-aminoacid
Deamidation followed by a methylation|DEAME
Deamidation|DEAM
Fluorenylmethyloxycarbonyl
Formylation|FORM
Galactosylation
Glucosylation (Glycation)|GLUC
Glycosylation
I/L uncertainty
iodo-4-azidosalicylic acid (IASA)
Hydroxylation
Hydroxylation and Galactosylation
Hydroxylation, Glucosylation, and Galactosylation
Main chain modification
Methylation|METH
Myristoylation|MYRI
N-acetylation
Nitration
Norleucine substitution
Oxidation
Palmitoylation|PALM
Phosphorylation|PHOS
Pyrrolidone carboxylic acid (Glu)|PYRE
Reduction
S-acetylmercaptoacetyl
Stereoisomer
Chain 2 Name
Chain 2 Accession
Source Organism
Starting Position
Equal To
After
Before
Between
And
Starting Position
Equal To
After
Before
Between
And
Tissue Type
BAL (bronchoalveolar lavage)
Blood
Bone Marrow
Breast
CNS (central nervous system)
CSF (cerebrospinal fluid)
Embryo
Eye
Gastrointestinal Tract
Heart
Kidney
Liver
Lung
Lymph Node
Lymphoid
Other
Pancreas
Peritoneal Fluid
Salivary Gland
Skin
Spleen
Synovial Fluid
Thymus
Umbilical Cord Blood
Derivative Type
Egg
Fruit/Vegetable
Gluten
Latex
Meat
Milk
Nut
Peanut
Pollen
Seed
Unspecified food product
Venom
Cell Type
293-T-Epithelial cell
Adherent cell
B cell
Basophil
C1R cells-B cell
Dendritic cell
EL-4 cells-Lymphoblast
Epithelial cell
Fibroblast
HeLa cells-Epithelial cell
Hepatocyte
JAWS II-dendritic cell
Jurkat-T cell
JY cells-B cell
L cells-Fibroblast
Lymph node cells
Lymphoblast
Lymphocyte
Macrophage
Mast cell
Mononuclear cell
NKT cells
Null
Other
P815-Mast cell
PBMC
Plasma cell
RMA-lymphocyte
Splenocyte
T cell
T cell CD3+
T cell CD3-
T cell CD4+
T cell CD4-
T cell CD8+
T cell CD8-
T cell CD8-/CD4-
T cell hybridoma
T cell γδ
T2 cells-Lymphoblast
Unknown/Unspecified
Origin
Direct Ex Vivo
Short Term Restimulated
Cell Line / Clone
Cell Line / Clone (EBV transformed, B-LCL)
Cell Line / Clone (Hybridoma)
Blast Activated
In Vivo
Other / Unknown
Epitope Reference Details
Epitope Structure Defines
Exact Epitope
Epitope containing region/antigenic site
Partial Epitope
Evidence Code for Epitope Source Antigen
Representative selection
Author provided Identifier
Exact match to reference information
Imperfect match
Internal Identifier-no external match available
Not determined
Epitope Name
Reference Start Position
Equal To
After
Before
Between
And
Reference End Position
Equal To
After
Before
Between
And
Reference Region
Comments
Location of Data in Reference
Epitope Related Object
Related Object
The epitope is an analog of:
The epitope is a mimotope of:
Type
Source Molecule
Source Organism
Object Type
Molecule Name
Discontinuous Residues
Peptide Sequence
Modified Residue(s)
Modification(s)
1,2-dimethylpropylamine
2-aminoisobutiric acid
4-azidobenzoic acid (ABA)
Acetylation|ACET
Amidation|AMID
Biotin|BIOT
Citrullination|CITR
Cysteinylation
D-aminoacid
Deamidation followed by a methylation|DEAME
Deamidation|DEAM
Fluorenylmethyloxycarbonyl
Formylation|FORM
Galactosylation
Glucosylation (Glycation)|GLUC
Glycosylation
I/L uncertainty
iodo-4-azidosalicylic acid (IASA)
Hydroxylation
Hydroxylation and Galactosylation
Hydroxylation, Glucosylation, and Galactosylation
Main chain modification
Methylation|METH
Myristoylation|MYRI
N-acetylation
Nitration
Norleucine substitution
Oxidation
Palmitoylation|PALM
Phosphorylation|PHOS
Pyrrolidone carboxylic acid (Glu)|PYRE
Reduction
S-acetylmercaptoacetyl
Stereoisomer
Chain 1 Name
Molecule Accession
Source Organism
Modified Residue(s)
Modification(s)
1,2-dimethylpropylamine
2-aminoisobutiric acid
4-azidobenzoic acid (ABA)
Acetylation|ACET
Amidation|AMID
Biotin|BIOT
Citrullination|CITR
Cysteinylation
D-aminoacid
Deamidation followed by a methylation|DEAME
Deamidation|DEAM
Fluorenylmethyloxycarbonyl
Formylation|FORM
Galactosylation
Glucosylation (Glycation)|GLUC
Glycosylation
I/L uncertainty
iodo-4-azidosalicylic acid (IASA)
Hydroxylation
Hydroxylation and Galactosylation
Hydroxylation, Glucosylation, and Galactosylation
Main chain modification
Methylation|METH
Myristoylation|MYRI
N-acetylation
Nitration
Norleucine substitution
Oxidation
Palmitoylation|PALM
Phosphorylation|PHOS
Pyrrolidone carboxylic acid (Glu)|PYRE
Reduction
S-acetylmercaptoacetyl
Stereoisomer
Chain 2 Name
Chain 2 Accession
Source Organism
Starting Position
Equal To
After
Before
Between
And
Starting Position
Equal To
After
Before
Between
And
Analog/Mimotope
BAL (bronchoalveolar lavage)
Blood
Bone Marrow
Breast
CNS (central nervous system)
CSF (cerebrospinal fluid)
Embryo
Eye
Gastrointestinal Tract
Heart
Kidney
Liver
Lung
Lymph Node
Lymphoid
Other
Pancreas
Peritoneal Fluid
Salivary Gland
Skin
Spleen
Synovial Fluid
Thymus
Umbilical Cord Blood
Derivative Type
Egg
Fruit/Vegetable
Gluten
Latex
Meat
Milk
Nut
Peanut
Pollen
Seed
Unspecified food product
Venom
Cell Type
293-T-Epithelial cell
Adherent cell
B cell
Basophil
C1R cells-B cell
Dendritic cell
EL-4 cells-Lymphoblast
Epithelial cell
Fibroblast
HeLa cells-Epithelial cell
Hepatocyte
JAWS II-dendritic cell
Jurkat-T cell
JY cells-B cell
L cells-Fibroblast
Lymph node cells
Lymphoblast
Lymphocyte
Macrophage
Mast cell
Mononuclear cell
NKT cells
Null
Other
P815-Mast cell
PBMC
Plasma cell
RMA-lymphocyte
Splenocyte
T cell
T cell CD3+
T cell CD3-
T cell CD4+
T cell CD4-
T cell CD8+
T cell CD8-
T cell CD8-/CD4-
T cell hybridoma
T cell γδ
T2 cells-Lymphoblast
Unknown/Unspecified
Origin
Direct Ex Vivo
Short Term Restimulated
Cell Line / Clone
Cell Line / Clone (EBV transformed, B-LCL)
Cell Line / Clone (Hybridoma)
Blast Activated
In Vivo
Other / Unknown
Immunization
Host Organism
Host Details
Sex
Male
Female
Age
MHC Types Present
1st In Vivo Process
may or may not
MUST
MUST NOT be present in search results.
In Vivo Process Type
Administration in vivo
Administration in vivo to cause disease
Administration in vivo to prevent or reduce disease
Occurrence of infectious disease
Occurrence of allergy
Occurrence of autoimmune disease
Occurrence of cancer
Occurrence of disease
Exposure with existing immune reactivity without evidence for disease
Documented exposure without evidence for disease
Environmental exposure to endemic/ubiquitous agent without evidence for disease
Exposure without evidence for disease
No immunization
Unknown
Disease State
Disease Stage
Acute/Recent onset
Chronic
Post
Unknown
Other
Administration Details
Adjuvants
ABM2
AS01B
AS02 (SBAS2)
ASO2A
Adjumer
Adjuvax
Algammulin
Alum (Aluminum hydroxide gel)
Aluminum phosphate
Aluminum potassium sulfate (alum)
Bordetella pertussis
Calcitriol
Chitosan
Cholera toxin
CpG
Dimethyldioctadecylammonium bromide (DDA)
Freund's adjuvant
Freund's complete
Freund's incomplete (IFA)
GM-CSF
GMDP
Gamma Inulin
Glycerol
HBSS (Hank's Balanced Salt Solution)
IL-12
IL-2
Imiquimod
Interferon-Gamma
ISCOM
Lipid Core Peptide (LCP)
Lipofectin
Lipopolysaccharide (LPS)
Liposomes
MLP+TDM
Monophosphoryl lipid A
Montanide IMS-1313
Montanide ISA 720
Montanide ISA-51
Montanide IS0-50
nor-MDP
Other
P1005 (non-ionic copolymer)
Pam3Cys (lipoprotein)
Poloxamer
QS21
RaLPS
Ribi
Saponin
Seppic ISA 720
Soybean Oil
Syntex Adjuvant Forumulation (SAF)
Synthetic polynucleotides (poly IC/ poly AU)
TiterMax
Tomatine
Vaxfectin
XtendIII
Zymosan
Route
Cervical
Conjunctival
In utero
Intraarterial
Intracarotid (i.c.)
Intracerebral
Intracranial
Intradermal
Intraepidermal (i.d.)
Intragastral / Intracolonic
Intralymphatic
Intramniotic
Intramuscular
Intranasal
Intraoccular
Intraperitoneal (i.p.)
Intraplacental
Intrarectal
Intrasplenic
Intratracheal
Intravenous (i.v.)
Oral
Other
Percutaneous/Skin patch
Scarification
Subcutaneous (s.c.)
Target lymph node immunization
Transcutaneous
Urethral
Vaginal
Dose Schedule
1st Immunogen
may or may not
MUST
MUST NOT be present in search results.
Epitope Relation
Epitope
Source Antigen
Source Organism
Fragment of Source Antigen
Derivative of Source Organism
Other Structure from Source Organism
Taxonomic Parent
Taxonomic Sibling
Taxonomic Child
Structurally Related
Other
Type
Source Molecule
Source Organism
Object Type
Molecule Name
Discontinuous Residues
Peptide Sequence
Modified Residue(s)
Modification(s)
1,2-dimethylpropylamine
2-aminoisobutiric acid
4-azidobenzoic acid (ABA)
Acetylation|ACET
Amidation|AMID
Biotin|BIOT
Citrullination|CITR
Cysteinylation
D-aminoacid
Deamidation followed by a methylation|DEAME
Deamidation|DEAM
Fluorenylmethyloxycarbonyl
Formylation|FORM
Galactosylation
Glucosylation (Glycation)|GLUC
Glycosylation
I/L uncertainty
iodo-4-azidosalicylic acid (IASA)
Hydroxylation
Hydroxylation and Galactosylation
Hydroxylation, Glucosylation, and Galactosylation
Main chain modification
Methylation|METH
Myristoylation|MYRI
N-acetylation
Nitration
Norleucine substitution
Oxidation
Palmitoylation|PALM
Phosphorylation|PHOS
Pyrrolidone carboxylic acid (Glu)|PYRE
Reduction
S-acetylmercaptoacetyl
Stereoisomer
Chain 1 Name
Molecule Accession
Source Organism
Modified Residue(s)
Modification(s)
1,2-dimethylpropylamine
2-aminoisobutiric acid
4-azidobenzoic acid (ABA)
Acetylation|ACET
Amidation|AMID
Biotin|BIOT
Citrullination|CITR
Cysteinylation
D-aminoacid
Deamidation followed by a methylation|DEAME
Deamidation|DEAM
Fluorenylmethyloxycarbonyl
Formylation|FORM
Galactosylation
Glucosylation (Glycation)|GLUC
Glycosylation
I/L uncertainty
iodo-4-azidosalicylic acid (IASA)
Hydroxylation
Hydroxylation and Galactosylation
Hydroxylation, Glucosylation, and Galactosylation
Main chain modification
Methylation|METH
Myristoylation|MYRI
N-acetylation
Nitration
Norleucine substitution
Oxidation
Palmitoylation|PALM
Phosphorylation|PHOS
Pyrrolidone carboxylic acid (Glu)|PYRE
Reduction
S-acetylmercaptoacetyl
Stereoisomer
Chain 2 Name
Chain 2 Accession
Source Organism
Starting Position
Equal To
After
Before
Between
And
Starting Position
Equal To
After
Before
Between
And
Tissue Type
BAL (bronchoalveolar lavage)
Blood
Bone Marrow
Breast
CNS (central nervous system)
CSF (cerebrospinal fluid)
Embryo
Eye
Gastrointestinal Tract
Heart
Kidney
Liver
Lung
Lymph Node
Lymphoid
Other
Pancreas
Peritoneal Fluid
Salivary Gland
Skin
Spleen
Synovial Fluid
Thymus
Umbilical Cord Blood
Derivative Type
Egg
Fruit/Vegetable
Gluten
Latex
Meat
Milk
Nut
Peanut
Pollen
Seed
Unspecified food product
Venom
Cell Type
293-T-Epithelial cell
Adherent cell
B cell
Basophil
C1R cells-B cell
Dendritic cell
EL-4 cells-Lymphoblast
Epithelial cell
Fibroblast
HeLa cells-Epithelial cell
Hepatocyte
JAWS II-dendritic cell
Jurkat-T cell
JY cells-B cell
L cells-Fibroblast
Lymph node cells
Lymphoblast
Lymphocyte
Macrophage
Mast cell
Mononuclear cell
NKT cells
Null
Other
P815-Mast cell
PBMC
Plasma cell
RMA-lymphocyte
Splenocyte
T cell
T cell CD3-
T cell CD3+
T cell CD4-
T cell CD4+
T cell CD8-
T cell CD8-/CD4-
T cell CD8+
T cell hybridoma
T cell γδ
T2 cells-Lymphoblast
Unknown/Unspecified
Origin
Direct Ex Vivo
Short Term Restimulated
Cell Line / Clone
Cell Line / Clone (EBV transformed, B-LCL)
Cell Line / Clone (Hybridoma)
Blast Activated
In Vivo
Other / Unknown
Immunogen Details
Immunogen Evidence Code
Representative selection
Author provided Identifier
Exact match to reference information
Imperfect match
Internal Identifier-no external match available
Not determined
Immunogen Reference Name
Immunogen Containing Object
Type
Source Molecule
Source Organism
Object Type
Molecule Name
Discontinuous Residues
Peptide Sequence
Modified Residue(s)
Modification(s)
1,2-dimethylpropylamine
2-aminoisobutiric acid
4-azidobenzoic acid (ABA)
Acetylation|ACET
Amidation|AMID
Biotin|BIOT
Citrullination|CITR
Cysteinylation
D-aminoacid
Deamidation followed by a methylation|DEAME
Deamidation|DEAM
Fluorenylmethyloxycarbonyl
Formylation|FORM
Galactosylation
Glucosylation (Glycation)|GLUC
Glycosylation
I/L uncertainty
iodo-4-azidosalicylic acid (IASA)
Hydroxylation
Hydroxylation and Galactosylation
Hydroxylation, Glucosylation, and Galactosylation
Main chain modification
Methylation|METH
Myristoylation|MYRI
N-acetylation
Nitration
Norleucine substitution
Oxidation
Palmitoylation|PALM
Phosphorylation|PHOS
Pyrrolidone carboxylic acid (Glu)|PYRE
Reduction
S-acetylmercaptoacetyl
Stereoisomer
Chain 1 Name
Molecule Accession
Source Organism
Modified Residue(s)
Modification(s)
1,2-dimethylpropylamine
2-aminoisobutiric acid
4-azidobenzoic acid (ABA)
Acetylation|ACET
Amidation|AMID
Biotin|BIOT
Citrullination|CITR
Cysteinylation
D-aminoacid
Deamidation followed by a methylation|DEAME
Deamidation|DEAM
Fluorenylmethyloxycarbonyl
Formylation|FORM
Galactosylation
Glucosylation (Glycation)|GLUC
Glycosylation
I/L uncertainty
iodo-4-azidosalicylic acid (IASA)
Hydroxylation
Hydroxylation and Galactosylation
Hydroxylation, Glucosylation, and Galactosylation
Main chain modification
Methylation|METH
Myristoylation|MYRI
N-acetylation
Nitration
Norleucine substitution
Oxidation
Palmitoylation|PALM
Phosphorylation|PHOS
Pyrrolidone carboxylic acid (Glu)|PYRE
Reduction
S-acetylmercaptoacetyl
Stereoisomer
Chain 2 Name
Chain 2 Accession
Source Organism
Starting Position
Equal To
After
Before
Between
And
Starting Position
Equal To
After
Before
Between
And
Tissue Type
BAL (bronchoalveolar lavage)
Blood
Bone Marrow
Breast
CNS (central nervous system)
CSF (cerebrospinal fluid)
Embryo
Eye
Gastrointestinal Tract
Heart
Kidney
Liver
Lung
Lymph Node
Lymphoid
Other
Pancreas
Peritoneal Fluid
Salivary Gland
Skin
Spleen
Synovial Fluid
Thymus
Umbilical Cord Blood
Derivative Type
Egg
Fruit/Vegetable
Gluten
Latex
Meat
Milk
Nut
Peanut
Pollen
Seed
Unspecified food product
Venom
Cell Type
293-T-Epithelial cell
Adherent cell
B cell
Basophil
C1R cells-B cell
Dendritic cell
EL-4 cells-Lymphoblast
Epithelial cell
Fibroblast
HeLa cells-Epithelial cell
Hepatocyte
JAWS II-dendritic cell
Jurkat-T cell
JY cells-B cell
L cells-Fibroblast
Lymph node cells
Lymphoblast
Lymphocyte
Macrophage
Mast cell
Mononuclear cell
NKT cells
Null
Other
P815-Mast cell
PBMC
Plasma cell
RMA-lymphocyte
Splenocyte
T cell
T cell CD3-
T cell CD3+
T cell CD4-
T cell CD4+
T cell CD8-
T cell CD8-/CD4-
T cell CD8+
T cell hybridoma
T cell γδ
T2 cells-Lymphoblast
Unknown/Unspecified
Origin
Direct Ex Vivo
Short Term Restimulated
Cell Line / Clone
Cell Line / Clone (EBV transformed, B-LCL)
Cell Line / Clone (Hybridoma)
Blast Activated
In Vivo
Other / Unknown
2nd In Vivo Process
may or may not
MUST
MUST NOT be present in search results.
In Vivo Process Type
Administration in vivo
Administration in vivo to cause disease
Administration in vivo to prevent or reduce disease
Occurrence of infectious disease
Occurrence of allergy
Occurrence of autoimmune disease
Occurrence of cancer
Occurrence of disease
Exposure with existing immune reactivity without evidence for disease
Documented exposure without evidence for disease
Environmental exposure to endemic/ubiquitous agent without evidence for disease
Exposure without evidence for disease
No immunization
Unknown
Disease State
Disease Stage
Acute/Recent onset
Chronic
Post
Unknown
Other
Administration Details
Adjuvants
ABM2
AS01B
AS02 (SBAS2)
ASO2A
Adjumer
Adjuvax
Algammulin
Alum (Aluminum hydroxide gel)
Aluminum phosphate
Aluminum potassium sulfate (alum)
Bordetella pertussis
Calcitriol
Chitosan
Cholera toxin
CpG
Dimethyldioctadecylammonium bromide (DDA)
Freund's adjuvant
Freund's complete
Freund's incomplete (IFA)
GM-CSF
GMDP
Gamma Inulin
Glycerol
HBSS (Hank's Balanced Salt Solution)
IL-12
IL-2
Imiquimod
Interferon-Gamma
ISCOM
Lipid Core Peptide (LCP)
Lipofectin
Lipopolysaccharide (LPS)
Liposomes
MLP+TDM
Monophosphoryl lipid A
Montanide IMS-1313
Montanide ISA 720
Montanide ISA-51
Montanide IS0-50
nor-MDP
Other
P1005 (non-ionic copolymer)
Pam3Cys (lipoprotein)
Poloxamer
QS21
RaLPS
Ribi
Saponin
Seppic ISA 720
Soybean Oil
Syntex Adjuvant Forumulation (SAF)
Synthetic polynucleotides (poly IC/ poly AU)
TiterMax
Tomatine
Vaxfectin
XtendIII
Zymosan
Route
Cervical
Conjunctival
In utero
Intraarterial
Intracarotid (i.c.)
Intracerebral
Intracranial
Intradermal
Intraepidermal (i.d.)
Intragastral / Intracolonic
Intralymphatic
Intramniotic
Intramuscular
Intranasal
Intraoccular
Intraperitoneal (i.p.)
Intraplacental
Intrarectal
Intrasplenic
Intratracheal
Intravenous (i.v.)
Oral
Other
Percutaneous/Skin patch
Scarification
Subcutaneous (s.c.)
Target lymph node immunization
Transcutaneous
Urethral
Vaginal
Dose Schedule
2nd Immunogen
may or may not
MUST
MUST NOT be present in search results.
Epitope Relation
Epitope
Source Antigen
Source Organism
Fragment of Source Antigen
Derivative of Source Organism
Other Structure from Source Organism
Taxonomic Parent
Taxonomic Sibling
Taxonomic Child
Structurally Related
Other
Type
Source Molecule
Source Organism
Object Type
Molecule Name
Discontinuous Residues
Peptide Sequence
Modified Residue(s)
Modification(s)
1,2-dimethylpropylamine
2-aminoisobutiric acid
4-azidobenzoic acid (ABA)
Acetylation|ACET
Amidation|AMID
Biotin|BIOT
Citrullination|CITR
Cysteinylation
D-aminoacid
Deamidation followed by a methylation|DEAME
Deamidation|DEAM
Fluorenylmethyloxycarbonyl
Formylation|FORM
Galactosylation
Glucosylation (Glycation)|GLUC
Glycosylation
I/L uncertainty
iodo-4-azidosalicylic acid (IASA)
Hydroxylation
Hydroxylation and Galactosylation
Hydroxylation, Glucosylation, and Galactosylation
Main chain modification
Methylation|METH
Myristoylation|MYRI
N-acetylation
Nitration
Norleucine substitution
Oxidation
Palmitoylation|PALM
Phosphorylation|PHOS
Pyrrolidone carboxylic acid (Glu)|PYRE
Reduction
S-acetylmercaptoacetyl
Stereoisomer
Chain 1 Name
Molecule Accession
Source Organism
Modified Residue(s)
Modification(s)
1,2-dimethylpropylamine
2-aminoisobutiric acid
4-azidobenzoic acid (ABA)
Acetylation|ACET
Amidation|AMID
Biotin|BIOT
Citrullination|CITR
Cysteinylation
D-aminoacid
Deamidation followed by a methylation|DEAME
Deamidation|DEAM
Fluorenylmethyloxycarbonyl
Formylation|FORM
Galactosylation
Glucosylation (Glycation)|GLUC
Glycosylation
I/L uncertainty
iodo-4-azidosalicylic acid (IASA)
Hydroxylation
Hydroxylation and Galactosylation
Hydroxylation, Glucosylation, and Galactosylation
Main chain modification
Methylation|METH
Myristoylation|MYRI
N-acetylation
Nitration
Norleucine substitution
Oxidation
Palmitoylation|PALM
Phosphorylation|PHOS
Pyrrolidone carboxylic acid (Glu)|PYRE
Reduction
S-acetylmercaptoacetyl
Stereoisomer
Chain 2 Name
Chain 2 Accession
Source Organism
Starting Position
Equal To
After
Before
Between
And
Starting Position
Equal To
After
Before
Between
And
Tissue Type
BAL (bronchoalveolar lavage)
Blood
Bone Marrow
Breast
CNS (central nervous system)
CSF (cerebrospinal fluid)
Embryo
Eye
Gastrointestinal Tract
Heart
Kidney
Liver
Lung
Lymph Node
Lymphoid
Other
Pancreas
Peritoneal Fluid
Salivary Gland
Skin
Spleen
Synovial Fluid
Thymus
Umbilical Cord Blood
Derivative Type
Egg
Fruit/Vegetable
Gluten
Latex
Meat
Milk
Nut
Peanut
Pollen
Seed
Unspecified food product
Venom
Cell Type
293-T-Epithelial cell
Adherent cell
B cell
Basophil
C1R cells-B cell
Dendritic cell
EL-4 cells-Lymphoblast
Epithelial cell
Fibroblast
HeLa cells-Epithelial cell
Hepatocyte
JAWS II-dendritic cell
Jurkat-T cell
JY cells-B cell
L cells-Fibroblast
Lymph node cells
Lymphoblast
Lymphocyte
Macrophage
Mast cell
Mononuclear cell
NKT cells
Null
Other
P815-Mast cell
PBMC
Plasma cell
RMA-lymphocyte
Splenocyte
T cell
T cell CD3-
T cell CD3+
T cell CD4-
T cell CD4+
T cell CD8-
T cell CD8-/CD4-
T cell CD8+
T cell hybridoma
T cell γδ
T2 cells-Lymphoblast
Unknown/Unspecified
Origin
Direct Ex Vivo
Short Term Restimulated
Cell Line / Clone
Cell Line / Clone (EBV transformed, B-LCL)
Cell Line / Clone (Hybridoma)
Blast Activated
In Vivo
Other / Unknown
Immunogen Details
Immunogen Evidence Code
Representative selection
Author provided Identifier
Exact match to reference information
Imperfect match
Internal Identifier-no external match available
Not determined
Immunogen Reference Name
Immunogen Containing Object
Type
Source Molecule
Source Organism
Object Type
Molecule Name
Discontinuous Residues
Peptide Sequence
Modified Residue(s)
Modification(s)
1,2-dimethylpropylamine
2-aminoisobutiric acid
4-azidobenzoic acid (ABA)
Acetylation|ACET
Amidation|AMID
Biotin|BIOT
Citrullination|CITR
Cysteinylation
D-aminoacid
Deamidation followed by a methylation|DEAME
Deamidation|DEAM
Fluorenylmethyloxycarbonyl
Formylation|FORM
Galactosylation
Glucosylation (Glycation)|GLUC
Glycosylation
I/L uncertainty
iodo-4-azidosalicylic acid (IASA)
Hydroxylation
Hydroxylation and Galactosylation
Hydroxylation, Glucosylation, and Galactosylation
Main chain modification
Methylation|METH
Myristoylation|MYRI
N-acetylation
Nitration
Norleucine substitution
Oxidation
Palmitoylation|PALM
Phosphorylation|PHOS
Pyrrolidone carboxylic acid (Glu)|PYRE
Reduction
S-acetylmercaptoacetyl
Stereoisomer
Chain 1 Name
Molecule Accession
Source Organism
Modified Residue(s)
Modification(s)
1,2-dimethylpropylamine
2-aminoisobutiric acid
4-azidobenzoic acid (ABA)
Acetylation|ACET
Amidation|AMID
Biotin|BIOT
Citrullination|CITR
Cysteinylation
D-aminoacid
Deamidation followed by a methylation|DEAME
Deamidation|DEAM
Fluorenylmethyloxycarbonyl
Formylation|FORM
Galactosylation
Glucosylation (Glycation)|GLUC
Glycosylation
I/L uncertainty
iodo-4-azidosalicylic acid (IASA)
Hydroxylation
Hydroxylation and Galactosylation
Hydroxylation, Glucosylation, and Galactosylation
Main chain modification
Methylation|METH
Myristoylation|MYRI
N-acetylation
Nitration
Norleucine substitution
Oxidation
Palmitoylation|PALM
Phosphorylation|PHOS
Pyrrolidone carboxylic acid (Glu)|PYRE
Reduction
S-acetylmercaptoacetyl
Stereoisomer
Chain 2 Name
Chain 2 Accession
Source Organism
Starting Position
Equal To
After
Before
Between
And
Starting Position
Equal To
After
Before
Between
And
Tissue Type
BAL (bronchoalveolar lavage)
Blood
Bone Marrow
Breast
CNS (central nervous system)
CSF (cerebrospinal fluid)
Embryo
Eye
Gastrointestinal Tract
Heart
Kidney
Liver
Lung
Lymph Node
Lymphoid
Other
Pancreas
Peritoneal Fluid
Salivary Gland
Skin
Spleen
Synovial Fluid
Thymus
Umbilical Cord Blood
Derivative Type
Egg
Fruit/Vegetable
Gluten
Latex
Meat
Milk
Nut
Peanut
Pollen
Seed
Unspecified food product
Venom
Cell Type
293-T-Epithelial cell
Adherent cell
B cell
Basophil
C1R cells-B cell
Dendritic cell
EL-4 cells-Lymphoblast
Epithelial cell
Fibroblast
HeLa cells-Epithelial cell
Hepatocyte
JAWS II-dendritic cell
Jurkat-T cell
JY cells-B cell
L cells-Fibroblast
Lymph node cells
Lymphoblast
Lymphocyte
Macrophage
Mast cell
Mononuclear cell
NKT cells
Null
Other
P815-Mast cell
PBMC
Plasma cell
RMA-lymphocyte
Splenocyte
T cell
T cell CD3-
T cell CD3+
T cell CD4-
T cell CD4+
T cell CD8-
T cell CD8-/CD4-
T cell CD8+
T cell hybridoma
T cell γδ
T2 cells-Lymphoblast
Unknown/Unspecified
Origin
Direct Ex Vivo
Short Term Restimulated
Cell Line / Clone
Cell Line / Clone (EBV transformed, B-LCL)
Cell Line / Clone (Hybridoma)
Blast Activated
In Vivo
Other / Unknown
In Vitro Administration
may or may not
MUST
MUST NOT be present in search results.
Process Type
Restimulation in vitro
Primary induction in vitro
Responder Cell Type
293-T-Epithelial cell
Adherent cell
B cell
Basophil
C1R cells-B cell
Dendritic cell
EL-4 cells-Lymphoblast
Epithelial cell
Fibroblast
HeLa cells-Epithelial cell
Hepatocyte
JAWS II-dendritic cell
Jurkat-T cell
JY cells-B cell
L cells-Fibroblast
Lymph node cells
Lymphoblast
Lymphocyte
Macrophage
Mast cell
Mononuclear cell
NKT cells
Null
Other
P815-Mast cell
PBMC
Plasma cell
RMA-lymphocyte
Splenocyte
T cell
T cell CD3-
T cell CD3+
T cell CD4-
T cell CD4+
T cell CD8-
T cell CD8-/CD4-
T cell CD8+
T cell hybridoma
T cell γδ
T2 cells-Lymphoblast
Unknown/Unspecified
Stimulator Cell Type
293-T-Epithelial cell
Adherent cell
B cell
Basophil
C1R cells-B cell
Dendritic cell
EL-4 cells-Lymphoblast
Epithelial cell
Fibroblast
HeLa cells-Epithelial cell
Hepatocyte
JAWS II-dendritic cell
Jurkat-T cell
JY cells-B cell
L cells-Fibroblast
Lymph node cells
Lymphoblast
Lymphocyte
Macrophage
Mast cell
Mononuclear cell
NKT cells
Null
Other
P815-Mast cell
PBMC
Plasma cell
RMA-lymphocyte
Splenocyte
T cell
T cell CD3-
T cell CD3+
T cell CD4-
T cell CD4+
T cell CD8-
T cell CD8-/CD4-
T cell CD8+
T cell hybridoma
T cell γδ
T2 cells-Lymphoblast
Unknown/Unspecified
In Vitro Immunogen
may or may not
MUST
MUST NOT be present in search results.
Epitope Relation
Epitope
Source Antigen
Source Organism
Fragment of Source Antigen
Derivative of Source Organism
Other Structure from Source Organism
Taxonomic Parent
Taxonomic Sibling
Taxonomic Child
Structurally Related
Other
Type
Source Molecule
Source Organism
Object Type
Molecule Name
Discontinuous Residues
Peptide Sequence
Modified Residue(s)
Modification(s)
1,2-dimethylpropylamine
2-aminoisobutiric acid
4-azidobenzoic acid (ABA)
Acetylation|ACET
Amidation|AMID
Biotin|BIOT
Citrullination|CITR
Cysteinylation
D-aminoacid
Deamidation followed by a methylation|DEAME
Deamidation|DEAM
Fluorenylmethyloxycarbonyl
Formylation|FORM
Galactosylation
Glucosylation (Glycation)|GLUC
Glycosylation
I/L uncertainty
iodo-4-azidosalicylic acid (IASA)
Hydroxylation
Hydroxylation and Galactosylation
Hydroxylation, Glucosylation, and Galactosylation
Main chain modification
Methylation|METH
Myristoylation|MYRI
N-acetylation
Nitration
Norleucine substitution
Oxidation
Palmitoylation|PALM
Phosphorylation|PHOS
Pyrrolidone carboxylic acid (Glu)|PYRE
Reduction
S-acetylmercaptoacetyl
Stereoisomer
Chain 1 Name
Molecule Accession
Source Organism
Modified Residue(s)
Modification(s)
1,2-dimethylpropylamine
2-aminoisobutiric acid
4-azidobenzoic acid (ABA)
Acetylation|ACET
Amidation|AMID
Biotin|BIOT
Citrullination|CITR
Cysteinylation
D-aminoacid
Deamidation followed by a methylation|DEAME
Deamidation|DEAM
Fluorenylmethyloxycarbonyl
Formylation|FORM
Galactosylation
Glucosylation (Glycation)|GLUC
Glycosylation
I/L uncertainty
iodo-4-azidosalicylic acid (IASA)
Hydroxylation
Hydroxylation and Galactosylation
Hydroxylation, Glucosylation, and Galactosylation
Main chain modification
Methylation|METH
Myristoylation|MYRI
N-acetylation
Nitration
Norleucine substitution
Oxidation
Palmitoylation|PALM
Phosphorylation|PHOS
Pyrrolidone carboxylic acid (Glu)|PYRE
Reduction
S-acetylmercaptoacetyl
Stereoisomer
Chain 2 Name
Chain 2 Accession
Source Organism
Starting Position
Equal To
After
Before
Between
And
Starting Position
Equal To
After
Before
Between
And
Tissue Type
BAL (bronchoalveolar lavage)
Blood
Bone Marrow
Breast
CNS (central nervous system)
CSF (cerebrospinal fluid)
Embryo
Eye
Gastrointestinal Tract
Heart
Kidney
Liver
Lung
Lymph Node
Lymphoid
Other
Pancreas
Peritoneal Fluid
Salivary Gland
Skin
Spleen
Synovial Fluid
Thymus
Umbilical Cord Blood
Derivative Type
Egg
Fruit/Vegetable
Gluten
Latex
Meat
Milk
Nut
Peanut
Pollen
Seed
Unspecified food product
Venom
Cell Type
293-T-Epithelial cell
Adherent cell
B cell
Basophil
C1R cells-B cell
Dendritic cell
EL-4 cells-Lymphoblast
Epithelial cell
Fibroblast
HeLa cells-Epithelial cell
Hepatocyte
JAWS II-dendritic cell
Jurkat-T cell
JY cells-B cell
L cells-Fibroblast
Lymph node cells
Lymphoblast
Lymphocyte
Macrophage
Mast cell
Mononuclear cell
NKT cells
Null
Other
P815-Mast cell
PBMC
Plasma cell
RMA-lymphocyte
Splenocyte
T cell
T cell CD3-
T cell CD3+
T cell CD4-
T cell CD4+
T cell CD8-
T cell CD8-/CD4-
T cell CD8+
T cell hybridoma
T cell γδ
T2 cells-Lymphoblast
Unknown/Unspecified
Origin
Direct Ex Vivo
Short Term Restimulated
Cell Line / Clone
Cell Line / Clone (EBV transformed, B-LCL)
Cell Line / Clone (Hybridoma)
Blast Activated
In Vivo
Other / Unknown
Immunogen Details
Immunogen Evidence Code
Representative selection
Author provided Identifier
Exact match to reference information
Imperfect match
Internal Identifier-no external match available
Not determined
Immunogen Reference Name
Immunogen Containing Object
Type
Source Molecule
Source Organism
Object Type
Molecule Name
Discontinuous Residues
Peptide Sequence
Modified Residue(s)
Modification(s)
1,2-dimethylpropylamine
2-aminoisobutiric acid
4-azidobenzoic acid (ABA)
Acetylation|ACET
Amidation|AMID
Biotin|BIOT
Citrullination|CITR
Cysteinylation
D-aminoacid
Deamidation followed by a methylation|DEAME
Deamidation|DEAM
Fluorenylmethyloxycarbonyl
Formylation|FORM
Galactosylation
Glucosylation (Glycation)|GLUC
Glycosylation
I/L uncertainty
iodo-4-azidosalicylic acid (IASA)
Hydroxylation
Hydroxylation and Galactosylation
Hydroxylation, Glucosylation, and Galactosylation
Main chain modification
Methylation|METH
Myristoylation|MYRI
N-acetylation
Nitration
Norleucine substitution
Oxidation
Palmitoylation|PALM
Phosphorylation|PHOS
Pyrrolidone carboxylic acid (Glu)|PYRE
Reduction
S-acetylmercaptoacetyl
Stereoisomer
Chain 1 Name
Molecule Accession
Source Organism
Modified Residue(s)
Modification(s)
1,2-dimethylpropylamine
2-aminoisobutiric acid
4-azidobenzoic acid (ABA)
Acetylation|ACET
Amidation|AMID
Biotin|BIOT
Citrullination|CITR
Cysteinylation
D-aminoacid
Deamidation followed by a methylation|DEAME
Deamidation|DEAM
Fluorenylmethyloxycarbonyl
Formylation|FORM
Galactosylation
Glucosylation (Glycation)|GLUC
Glycosylation
I/L uncertainty
iodo-4-azidosalicylic acid (IASA)
Hydroxylation
Hydroxylation and Galactosylation
Hydroxylation, Glucosylation, and Galactosylation
Main chain modification
Methylation|METH
Myristoylation|MYRI
N-acetylation
Nitration
Norleucine substitution
Oxidation
Palmitoylation|PALM
Phosphorylation|PHOS
Pyrrolidone carboxylic acid (Glu)|PYRE
Reduction
S-acetylmercaptoacetyl
Stereoisomer
Chain 2 Name
Chain 2 Accession
Source Organism
Starting Position
Equal To
After
Before
Between
And
Starting Position
Equal To
After
Before
Between
And
Tissue Type
BAL (bronchoalveolar lavage)
Blood
Bone Marrow
Breast
CNS (central nervous system)
CSF (cerebrospinal fluid)
Embryo
Eye
Gastrointestinal Tract
Heart
Kidney
Liver
Lung
Lymph Node
Lymphoid
Other
Pancreas
Peritoneal Fluid
Salivary Gland
Skin
Spleen
Synovial Fluid
Thymus
Umbilical Cord Blood
Derivative Type
Egg
Fruit/Vegetable
Gluten
Latex
Meat
Milk
Nut
Peanut
Pollen
Seed
Unspecified food product
Venom
Cell Type
293-T-Epithelial cell
Adherent cell
B cell
Basophil
C1R cells-B cell
Dendritic cell
EL-4 cells-Lymphoblast
Epithelial cell
Fibroblast
HeLa cells-Epithelial cell
Hepatocyte
JAWS II-dendritic cell
Jurkat-T cell
JY cells-B cell
L cells-Fibroblast
Lymph node cells
Lymphoblast
Lymphocyte
Macrophage
Mast cell
Mononuclear cell
NKT cells
Null
Other
P815-Mast cell
PBMC
Plasma cell
RMA-lymphocyte
Splenocyte
T cell
T cell CD3-
T cell CD3+
T cell CD4-
T cell CD4+
T cell CD8-
T cell CD8-/CD4-
T cell CD8+
T cell hybridoma
T cell γδ
T2 cells-Lymphoblast
Unknown/Unspecified
Origin
Direct Ex Vivo
Short Term Restimulated
Cell Line / Clone
Cell Line / Clone (EBV transformed, B-LCL)
Cell Line / Clone (Hybridoma)
Blast Activated
In Vivo
Other / Unknown
Immunization Comments
Immunization Comments
Adoptive Transfer
may or may not
MUST
MUST NOT be present in search results.
Recipient Organism
Recipient Organism Details
Sex
Male
Female
Age
Recipient MHC Types Present
Adoptive Transfer TCR Molecule
Transferred TCR Molecule Name
Transfered TCR Molecule Chain 1 Type
Alpha
Beta
Beta-1
Beta-2
Delta
Gamma-1
Gamma-2
Other
Transfered TCR Molecule Chain 2 Type
Alpha
Beta
Beta-1
Beta-2
Delta
Gamma-1
Gamma-2
Other
Transferred TCR Object
Type
Source Molecule
Source Organism
Object Type
Molecule Name
Discontinuous Residues
Peptide Sequence
Modified Residue(s)
Modification(s)
1,2-dimethylpropylamine
2-aminoisobutiric acid
4-azidobenzoic acid (ABA)
Acetylation|ACET
Amidation|AMID
Biotin|BIOT
Citrullination|CITR
Cysteinylation
D-aminoacid
Deamidation followed by a methylation|DEAME
Deamidation|DEAM
Fluorenylmethyloxycarbonyl
Formylation|FORM
Galactosylation
Glucosylation (Glycation)|GLUC
Glycosylation
I/L uncertainty
iodo-4-azidosalicylic acid (IASA)
Hydroxylation
Hydroxylation and Galactosylation
Hydroxylation, Glucosylation, and Galactosylation
Main chain modification
Methylation|METH
Myristoylation|MYRI
N-acetylation
Nitration
Norleucine substitution
Oxidation
Palmitoylation|PALM
Phosphorylation|PHOS
Pyrrolidone carboxylic acid (Glu)|PYRE
Reduction
S-acetylmercaptoacetyl
Stereoisomer
Chain 1 Name
Molecule Accession
Source Organism
Modified Residue(s)
Modification(s)
1,2-dimethylpropylamine
2-aminoisobutiric acid
4-azidobenzoic acid (ABA)
Acetylation|ACET
Amidation|AMID
Biotin|BIOT
Citrullination|CITR
Cysteinylation
D-aminoacid
Deamidation followed by a methylation|DEAME
Deamidation|DEAM
Fluorenylmethyloxycarbonyl
Formylation|FORM
Galactosylation
Glucosylation (Glycation)|GLUC
Glycosylation
I/L uncertainty
iodo-4-azidosalicylic acid (IASA)
Hydroxylation
Hydroxylation and Galactosylation
Hydroxylation, Glucosylation, and Galactosylation
Main chain modification
Methylation|METH
Myristoylation|MYRI
N-acetylation
Nitration
Norleucine substitution
Oxidation
Palmitoylation|PALM
Phosphorylation|PHOS
Pyrrolidone carboxylic acid (Glu)|PYRE
Reduction
S-acetylmercaptoacetyl
Stereoisomer
Chain 2 Name
Chain 2 Accession
Source Organism
Starting Position
Equal To
After
Before
Between
And
Starting Position
Equal To
After
Before
Between
And
Tissue Type
BAL (bronchoalveolar lavage)
Blood
Bone Marrow
Breast
CNS (central nervous system)
CSF (cerebrospinal fluid)
Embryo
Eye
Gastrointestinal Tract
Heart
Kidney
Liver
Lung
Lymph Node
Lymphoid
Other
Pancreas
Peritoneal Fluid
Salivary Gland
Skin
Spleen
Synovial Fluid
Thymus
Umbilical Cord Blood
Derivative Type
Egg
Fruit/Vegetable
Gluten
Latex
Meat
Milk
Nut
Peanut
Pollen
Seed
Unspecified food product
Venom
Cell Type
293-T-Epithelial cell
Adherent cell
B cell
Basophil
C1R cells-B cell
Dendritic cell
EL-4 cells-Lymphoblast
Epithelial cell
Fibroblast
HeLa cells-Epithelial cell
Hepatocyte
JAWS II-dendritic cell
Jurkat-T cell
JY cells-B cell
L cells-Fibroblast
Lymph node cells
Lymphoblast
Lymphocyte
Macrophage
Mast cell
Mononuclear cell
NKT cells
Null
Other
P815-Mast cell
PBMC
Plasma cell
RMA-lymphocyte
Splenocyte
T cell
T cell CD3-
T cell CD3+
T cell CD4-
T cell CD4+
T cell CD8-
T cell CD8-/CD4-
T cell CD8+
T cell hybridoma
T cell γδ
T2 cells-Lymphoblast
Unknown/Unspecified
Origin
Direct Ex Vivo
Short Term Restimulated
Cell Line / Clone
Cell Line / Clone (EBV transformed, B-LCL)
Cell Line / Clone (Hybridoma)
Blast Activated
In Vivo
Other / Unknown
Adoptive Transfer In Vivo Process In Recipient
may or may not
MUST
MUST NOT be present in search results.
In Vivo Process Type
Administration in vivo
Administration in vivo to cause disease
Administration in vivo to prevent or reduce disease
Occurrence of infectious disease
Occurrence of allergy
Occurrence of autoimmune disease
Occurrence of cancer
Occurrence of disease
Exposure with existing immune reactivity without evidence for disease
Documented exposure without evidence for disease
Environmental exposure to endemic/ubiquitous agent without evidence for disease
Exposure without evidence for disease
No immunization
Unknown
Disease State
Disease Stage
Acute/Recent onset
Chronic
Post
Unknown
Other
Administration Details
Adjuvants
ABM2
AS01B
AS02 (SBAS2)
ASO2A
Adjumer
Adjuvax
Algammulin
Alum (Aluminum hydroxide gel)
Aluminum phosphate
Aluminum potassium sulfate (alum)
Bordetella pertussis
Calcitriol
Chitosan
Cholera toxin
CpG
Dimethyldioctadecylammonium bromide (DDA)
Freund's adjuvant
Freund's complete
Freund's incomplete (IFA)
GM-CSF
GMDP
Gamma Inulin
Glycerol
HBSS (Hank's Balanced Salt Solution)
IL-12
IL-2
Imiquimod
Interferon-Gamma
ISCOM
Lipid Core Peptide (LCP)
Lipofectin
Lipopolysaccharide (LPS)
Liposomes
MLP+TDM
Monophosphoryl lipid A
Montanide IMS-1313
Montanide ISA 720
Montanide ISA-51
Montanide IS0-50
nor-MDP
Other
P1005 (non-ionic copolymer)
Pam3Cys (lipoprotein)
Poloxamer
QS21
RaLPS
Ribi
Saponin
Seppic ISA 720
Soybean Oil
Syntex Adjuvant Forumulation (SAF)
Synthetic polynucleotides (poly IC/ poly AU)
TiterMax
Tomatine
Vaxfectin
XtendIII
Zymosan
Route
Cervical
Conjunctival
In utero
Intraarterial
Intracarotid (i.c.)
Intracerebral
Intracranial
Intradermal
Intraepidermal (i.d.)
Intragastral / Intracolonic
Intralymphatic
Intramniotic
Intramuscular
Intranasal
Intraoccular
Intraperitoneal (i.p.)
Intraplacental
Intrarectal
Intrasplenic
Intratracheal
Intravenous (i.v.)
Oral
Other
Percutaneous/Skin patch
Scarification
Subcutaneous (s.c.)
Target lymph node immunization
Transcutaneous
Urethral
Vaginal
Dose Schedule
Immunogen
Epitope Relation
Epitope
Source Antigen
Source Organism
Fragment of Source Antigen
Derivative of Source Organism
Other Structure from Source Organism
Taxonomic Parent
Taxonomic Sibling
Taxonomic Child
Structurally Related
Other
Type
Source Molecule
Source Organism
Object Type
Molecule Name
Discontinuous Residues
Peptide Sequence
Modified Residue(s)
Modification(s)
1,2-dimethylpropylamine
2-aminoisobutiric acid
4-azidobenzoic acid (ABA)
Acetylation|ACET
Amidation|AMID
Biotin|BIOT
Citrullination|CITR
Cysteinylation
D-aminoacid
Deamidation followed by a methylation|DEAME
Deamidation|DEAM
Fluorenylmethyloxycarbonyl
Formylation|FORM
Galactosylation
Glucosylation (Glycation)|GLUC
Glycosylation
I/L uncertainty
iodo-4-azidosalicylic acid (IASA)
Hydroxylation
Hydroxylation and Galactosylation
Hydroxylation, Glucosylation, and Galactosylation
Main chain modification
Methylation|METH
Myristoylation|MYRI
N-acetylation
Nitration
Norleucine substitution
Oxidation
Palmitoylation|PALM
Phosphorylation|PHOS
Pyrrolidone carboxylic acid (Glu)|PYRE
Reduction
S-acetylmercaptoacetyl
Stereoisomer
Chain 1 Name
Molecule Accession
Source Organism
Modified Residue(s)
Modification(s)
1,2-dimethylpropylamine
2-aminoisobutiric acid
4-azidobenzoic acid (ABA)
Acetylation|ACET
Amidation|AMID
Biotin|BIOT
Citrullination|CITR
Cysteinylation
D-aminoacid
Deamidation followed by a methylation|DEAME
Deamidation|DEAM
Fluorenylmethyloxycarbonyl
Formylation|FORM
Galactosylation
Glucosylation (Glycation)|GLUC
Glycosylation
I/L uncertainty
iodo-4-azidosalicylic acid (IASA)
Hydroxylation
Hydroxylation and Galactosylation
Hydroxylation, Glucosylation, and Galactosylation
Main chain modification
Methylation|METH
Myristoylation|MYRI
N-acetylation
Nitration
Norleucine substitution
Oxidation
Palmitoylation|PALM
Phosphorylation|PHOS
Pyrrolidone carboxylic acid (Glu)|PYRE
Reduction
S-acetylmercaptoacetyl
Stereoisomer
Chain 2 Name
Chain 2 Accession
Source Organism
Starting Position
Equal To
After
Before
Between
And
Starting Position
Equal To
After
Before
Between
And
Tissue Type
BAL (bronchoalveolar lavage)
Blood
Bone Marrow
Breast
CNS (central nervous system)
CSF (cerebrospinal fluid)
Embryo
Eye
Gastrointestinal Tract
Heart
Kidney
Liver
Lung
Lymph Node
Lymphoid
Other
Pancreas
Peritoneal Fluid
Salivary Gland
Skin
Spleen
Synovial Fluid
Thymus
Umbilical Cord Blood
Derivative Type
Egg
Fruit/Vegetable
Gluten
Latex
Meat
Milk
Nut
Peanut
Pollen
Seed
Unspecified food product
Venom
Cell Type
293-T-Epithelial cell
Adherent cell
B cell
Basophil
C1R cells-B cell
Dendritic cell
EL-4 cells-Lymphoblast
Epithelial cell
Fibroblast
HeLa cells-Epithelial cell
Hepatocyte
JAWS II-dendritic cell
Jurkat-T cell
JY cells-B cell
L cells-Fibroblast
Lymph node cells
Lymphoblast
Lymphocyte
Macrophage
Mast cell
Mononuclear cell
NKT cells
Null
Other
P815-Mast cell
PBMC
Plasma cell
RMA-lymphocyte
Splenocyte
T cell
T cell CD3-
T cell CD3+
T cell CD4-
T cell CD4+
T cell CD8-
T cell CD8-/CD4-
T cell CD8+
T cell hybridoma
T cell γδ
T2 cells-Lymphoblast
Unknown/Unspecified
Origin
Direct Ex Vivo
Short Term Restimulated
Cell Line / Clone
Cell Line / Clone (EBV transformed, B-LCL)
Cell Line / Clone (Hybridoma)
Blast Activated
In Vivo
Other / Unknown
Immunogen Details
Immunogen Evidence Code
Representative selection
Author provided Identifier
Exact match to reference information
Imperfect match
Internal Identifier-no external match available
Not determined
Immunogen Reference Name
Immunogen Containing Object
Type
Source Molecule
Source Organism
Object Type
Molecule Name
Discontinuous Residues
Peptide Sequence
Modified Residue(s)
Modification(s)
1,2-dimethylpropylamine
2-aminoisobutiric acid
4-azidobenzoic acid (ABA)
Acetylation|ACET
Amidation|AMID
Biotin|BIOT
Citrullination|CITR
Cysteinylation
D-aminoacid
Deamidation followed by a methylation|DEAME
Deamidation|DEAM
Fluorenylmethyloxycarbonyl
Formylation|FORM
Galactosylation
Glucosylation (Glycation)|GLUC
Glycosylation
I/L uncertainty
iodo-4-azidosalicylic acid (IASA)
Hydroxylation
Hydroxylation and Galactosylation
Hydroxylation, Glucosylation, and Galactosylation
Main chain modification
Methylation|METH
Myristoylation|MYRI
N-acetylation
Nitration
Norleucine substitution
Oxidation
Palmitoylation|PALM
Phosphorylation|PHOS
Pyrrolidone carboxylic acid (Glu)|PYRE
Reduction
S-acetylmercaptoacetyl
Stereoisomer
Chain 1 Name
Molecule Accession
Source Organism
Modified Residue(s)
Modification(s)
1,2-dimethylpropylamine
2-aminoisobutiric acid
4-azidobenzoic acid (ABA)
Acetylation|ACET
Amidation|AMID
Biotin|BIOT
Citrullination|CITR
Cysteinylation
D-aminoacid
Deamidation followed by a methylation|DEAME
Deamidation|DEAM
Fluorenylmethyloxycarbonyl
Formylation|FORM
Galactosylation
Glucosylation (Glycation)|GLUC
Glycosylation
I/L uncertainty
iodo-4-azidosalicylic acid (IASA)
Hydroxylation
Hydroxylation and Galactosylation
Hydroxylation, Glucosylation, and Galactosylation
Main chain modification
Methylation|METH
Myristoylation|MYRI
N-acetylation
Nitration
Norleucine substitution
Oxidation
Palmitoylation|PALM
Phosphorylation|PHOS
Pyrrolidone carboxylic acid (Glu)|PYRE
Reduction
S-acetylmercaptoacetyl
Stereoisomer
Chain 2 Name
Chain 2 Accession
Source Organism
Starting Position
Equal To
After
Before
Between
And
Starting Position
Equal To
After
Before
Between
And
Tissue Type
BAL (bronchoalveolar lavage)
Blood
Bone Marrow
Breast
CNS (central nervous system)
CSF (cerebrospinal fluid)
Embryo
Eye
Gastrointestinal Tract
Heart
Kidney
Liver
Lung
Lymph Node
Lymphoid
Other
Pancreas
Peritoneal Fluid
Salivary Gland
Skin
Spleen
Synovial Fluid
Thymus
Umbilical Cord Blood
Derivative Type
Egg
Fruit/Vegetable
Gluten
Latex
Meat
Milk
Nut
Peanut
Pollen
Seed
Unspecified food product
Venom
Cell Type
293-T-Epithelial cell
Adherent cell
B cell
Basophil
C1R cells-B cell
Dendritic cell
EL-4 cells-Lymphoblast
Epithelial cell
Fibroblast
HeLa cells-Epithelial cell
Hepatocyte
JAWS II-dendritic cell
Jurkat-T cell
JY cells-B cell
L cells-Fibroblast
Lymph node cells
Lymphoblast
Lymphocyte
Macrophage
Mast cell
Mononuclear cell
NKT cells
Null
Other
P815-Mast cell
PBMC
Plasma cell
RMA-lymphocyte
Splenocyte
T cell
T cell CD3-
T cell CD3+
T cell CD4-
T cell CD4+
T cell CD8-
T cell CD8-/CD4-
T cell CD8+
T cell hybridoma
T cell γδ
T2 cells-Lymphoblast
Unknown/Unspecified
Origin
Direct Ex Vivo
Short Term Restimulated
Cell Line / Clone
Cell Line / Clone (EBV transformed, B-LCL)
Cell Line / Clone (Hybridoma)
Blast Activated
In Vivo
Other / Unknown
Adoptive Transfer Comments
Adoptive Transfer Comments
T Cell Assay
Qualitative Measurement
Positive
Positive-Low
Positive-Intermediate
Positive-High
Negative
Assay Type
Measurement Details
Measurement Inequality
=
>
<
>=
<=
Quantitative Measurement
Equal To
Above
Below
Between
And
Number of Subjects Tested
Equal To
Above
Below
Between
And
Number of Subjects Responded
Equal To
Above
Below
Between
And
Response Frequency (%)
Equal To
Above
Below
Between
And
Effector Cells
Effector Cell Tissue Type
BAL (bronchoalveolar lavage)
Blood
Bone Marrow
Breast
CNS (central nervous system)
CSF (cerebrospinal fluid)
Embryo
Eye
Gastrointestinal Tract
Heart
Kidney
Liver
Lung
Lymph Node
Lymphoid
Other
Pancreas
Peritoneal Fluid
Salivary Gland
Skin
Spleen
Synovial Fluid
Thymus
Umbilical Cord Blood
Effector Cell Type
293-T-Epithelial cell
Adherent cell
B cell
Basophil
C1R cells-B cell
Dendritic cell
EL-4 cells-Lymphoblast
Epithelial cell
Fibroblast
HeLa cells-Epithelial cell
Hepatocyte
JAWS II-dendritic cell
Jurkat-T cell
JY cells-B cell
L cells-Fibroblast
Lymph node cells
Lymphoblast
Lymphocyte
Macrophage
Mast cell
Mononuclear cell
NKT cells
Null
Other
P815-Mast cell
PBMC
Plasma cell
RMA-lymphocyte
Splenocyte
T cell
T cell CD3-
T cell CD3+
T cell CD4-
T cell CD4+
T cell CD8-
T cell CD8-/CD4-
T cell CD8+
T cell hybridoma
T cell γδ
T2 cells-Lymphoblast
Unknown/Unspecified
Effector Cell Culture Conditions
Direct Ex Vivo
Short Term Restimulated
Cell Line / Clone
Cell Line / Clone (EBV transformed, B-LCL)
Cell Line / Clone (Hybridoma)
Blast Activated
In Vivo
Other / Unknown
Assayed TCR Molecule
Assayed TCR Molecule Name
Assayed TCR Molecule Chain 1 Type
Alpha
Beta
Beta-1
Beta-2
Delta
Gamma-1
Gamma-2
Other
Assayed TCR Molecule Chain 2 Type
Alpha
Beta
Beta-1
Beta-2
Delta
Gamma-1
Gamma-2
Other
Assayed TCR Object
Type
Source Molecule
Source Organism
Object Type
Molecule Name
Discontinuous Residues
Peptide Sequence
Modified Residue(s)
Modification(s)
1,2-dimethylpropylamine
2-aminoisobutiric acid
4-azidobenzoic acid (ABA)
Acetylation|ACET
Amidation|AMID
Biotin|BIOT
Citrullination|CITR
Cysteinylation
D-aminoacid
Deamidation followed by a methylation|DEAME
Deamidation|DEAM
Fluorenylmethyloxycarbonyl
Formylation|FORM
Galactosylation
Glucosylation (Glycation)|GLUC
Glycosylation
I/L uncertainty
iodo-4-azidosalicylic acid (IASA)
Hydroxylation
Hydroxylation and Galactosylation
Hydroxylation, Glucosylation, and Galactosylation
Main chain modification
Methylation|METH
Myristoylation|MYRI
N-acetylation
Nitration
Norleucine substitution
Oxidation
Palmitoylation|PALM
Phosphorylation|PHOS
Pyrrolidone carboxylic acid (Glu)|PYRE
Reduction
S-acetylmercaptoacetyl
Stereoisomer
Chain 1 Name
Molecule Accession
Source Organism
Modified Residue(s)
Modification(s)
1,2-dimethylpropylamine
2-aminoisobutiric acid
4-azidobenzoic acid (ABA)
Acetylation|ACET
Amidation|AMID
Biotin|BIOT
Citrullination|CITR
Cysteinylation
D-aminoacid
Deamidation followed by a methylation|DEAME
Deamidation|DEAM
Fluorenylmethyloxycarbonyl
Formylation|FORM
Galactosylation
Glucosylation (Glycation)|GLUC
Glycosylation
I/L uncertainty
iodo-4-azidosalicylic acid (IASA)
Hydroxylation
Hydroxylation and Galactosylation
Hydroxylation, Glucosylation, and Galactosylation
Main chain modification
Methylation|METH
Myristoylation|MYRI
N-acetylation
Nitration
Norleucine substitution
Oxidation
Palmitoylation|PALM
Phosphorylation|PHOS
Pyrrolidone carboxylic acid (Glu)|PYRE
Reduction
S-acetylmercaptoacetyl
Stereoisomer
Chain 2 Name
Chain 2 Accession
Source Organism
Starting Position
Equal To
After
Before
Between
And
Starting Position
Equal To
After
Before
Between
And
Tissue Type
BAL (bronchoalveolar lavage)
Blood
Bone Marrow
Breast
CNS (central nervous system)
CSF (cerebrospinal fluid)
Embryo
Eye
Gastrointestinal Tract
Heart
Kidney
Liver
Lung
Lymph Node
Lymphoid
Other
Pancreas
Peritoneal Fluid
Salivary Gland
Skin
Spleen
Synovial Fluid
Thymus
Umbilical Cord Blood
Derivative Type
Egg
Fruit/Vegetable
Gluten
Latex
Meat
Milk
Nut
Peanut
Pollen
Seed
Unspecified food product
Venom
Cell Type
293-T-Epithelial cell
Adherent cell
B cell
Basophil
C1R cells-B cell
Dendritic cell
EL-4 cells-Lymphoblast
Epithelial cell
Fibroblast
HeLa cells-Epithelial cell
Hepatocyte
JAWS II-dendritic cell
Jurkat-T cell
JY cells-B cell
L cells-Fibroblast
Lymph node cells
Lymphoblast
Lymphocyte
Macrophage
Mast cell
Mononuclear cell
NKT cells
Null
Other
P815-Mast cell
PBMC
Plasma cell
RMA-lymphocyte
Splenocyte
T cell
T cell CD3-
T cell CD3+
T cell CD4-
T cell CD4+
T cell CD8-
T cell CD8-/CD4-
T cell CD8+
T cell hybridoma
T cell γδ
T2 cells-Lymphoblast
Unknown/Unspecified
Origin
Direct Ex Vivo
Short Term Restimulated
Cell Line / Clone
Cell Line / Clone (EBV transformed, B-LCL)
Cell Line / Clone (Hybridoma)
Blast Activated
In Vivo
Other / Unknown
Antigen Presenting Cells
Cell Tissue Type
BAL (bronchoalveolar lavage)
Blood
Bone Marrow
Breast
CNS (central nervous system)
CSF (cerebrospinal fluid)
Embryo
Eye
Gastrointestinal Tract
Heart
Kidney
Liver
Lung
Lymph Node
Lymphoid
Other
Pancreas
Peritoneal Fluid
Salivary Gland
Skin
Spleen
Synovial Fluid
Thymus
Umbilical Cord Blood
Cell Type
293-T-Epithelial cell
Adherent cell
B cell
Basophil
C1R cells-B cell
Dendritic cell
EL-4 cells-Lymphoblast
Epithelial cell
Fibroblast
HeLa cells-Epithelial cell
Hepatocyte
JAWS II-dendritic cell
Jurkat-T cell
JY cells-B cell
L cells-Fibroblast
Lymph node cells
Lymphoblast
Lymphocyte
Macrophage
Mast cell
Mononuclear cell
NKT cells
Null
Other
P815-Mast cell
PBMC
Plasma cell
RMA-lymphocyte
Splenocyte
T cell
T cell CD3-
T cell CD3+
T cell CD4-
T cell CD4+
T cell CD8-
T cell CD8-/CD4-
T cell CD8+
T cell hybridoma
T cell γδ
T2 cells-Lymphoblast
Unknown/Unspecified
Cell Culture Conditions
Direct Ex Vivo
Short Term Restimulated
Cell Line / Clone
Cell Line / Clone (EBV transformed, B-LCL)
Cell Line / Clone (Hybridoma)
Blast Activated
In Vivo
Other / Unknown
Autologous or Syngeneic
Yes
No
None
Cell Source Organism
Sex
Male
Female
Age
MHC Allele
MHC Allele Name
MHC Evidence Code
Cited reference
MHC binding assay
T cell assay -Single MHC type present
T cell assay -MHC subset identification
T cell assay -Mismatched MHC molecules
T cell assay -T cell subset identification
T cell assay -Biological process measured
MHC binding prediction
Statistical association
Antigen
Epitope Relation
Epitope
Source Antigen
Source Organism
Fragment of Source Antigen
Derivative of Source Organism
Other Structure from Source Organism
Taxonomic Parent
Taxonomic Sibling
Taxonomic Child
Structurally Related
Other
Type
Source Molecule
Source Organism
Object Type
Molecule Name
Discontinuous Residues
Peptide Sequence
Modified Residue(s)
Modification(s)
1,2-dimethylpropylamine
2-aminoisobutiric acid
4-azidobenzoic acid (ABA)
Acetylation|ACET
Amidation|AMID
Biotin|BIOT
Citrullination|CITR
Cysteinylation
D-aminoacid
Deamidation followed by a methylation|DEAME
Deamidation|DEAM
Fluorenylmethyloxycarbonyl
Formylation|FORM
Galactosylation
Glucosylation (Glycation)|GLUC
Glycosylation
I/L uncertainty
iodo-4-azidosalicylic acid (IASA)
Hydroxylation
Hydroxylation and Galactosylation
Hydroxylation, Glucosylation, and Galactosylation
Main chain modification
Methylation|METH
Myristoylation|MYRI
N-acetylation
Nitration
Norleucine substitution
Oxidation
Palmitoylation|PALM
Phosphorylation|PHOS
Pyrrolidone carboxylic acid (Glu)|PYRE
Reduction
S-acetylmercaptoacetyl
Stereoisomer
Chain 1 Name
Molecule Accession
Source Organism
Modified Residue(s)
Modification(s)
1,2-dimethylpropylamine
2-aminoisobutiric acid
4-azidobenzoic acid (ABA)
Acetylation|ACET
Amidation|AMID
Biotin|BIOT
Citrullination|CITR
Cysteinylation
D-aminoacid
Deamidation followed by a methylation|DEAME
Deamidation|DEAM
Fluorenylmethyloxycarbonyl
Formylation|FORM
Galactosylation
Glucosylation (Glycation)|GLUC
Glycosylation
I/L uncertainty
iodo-4-azidosalicylic acid (IASA)
Hydroxylation
Hydroxylation and Galactosylation
Hydroxylation, Glucosylation, and Galactosylation
Main chain modification
Methylation|METH
Myristoylation|MYRI
N-acetylation
Nitration
Norleucine substitution
Oxidation
Palmitoylation|PALM
Phosphorylation|PHOS
Pyrrolidone carboxylic acid (Glu)|PYRE
Reduction
S-acetylmercaptoacetyl
Stereoisomer
Chain 2 Name
Chain 2 Accession
Source Organism
Starting Position
Equal To
After
Before
Between
And
Starting Position
Equal To
After
Before
Between
And
Tissue Type
BAL (bronchoalveolar lavage)
Blood
Bone Marrow
Breast
CNS (central nervous system)
CSF (cerebrospinal fluid)
Embryo
Eye
Gastrointestinal Tract
Heart
Kidney
Liver
Lung
Lymph Node
Lymphoid
Other
Pancreas
Peritoneal Fluid
Salivary Gland
Skin
Spleen
Synovial Fluid
Thymus
Umbilical Cord Blood
Derivative Type
Egg
Fruit/Vegetable
Gluten
Latex
Meat
Milk
Nut
Peanut
Pollen
Seed
Unspecified food product
Venom
Cell Type
293-T-Epithelial cell
Adherent cell
B cell
Basophil
C1R cells-B cell
Dendritic cell
EL-4 cells-Lymphoblast
Epithelial cell
Fibroblast
HeLa cells-Epithelial cell
Hepatocyte
JAWS II-dendritic cell
Jurkat-T cell
JY cells-B cell
L cells-Fibroblast
Lymph node cells
Lymphoblast
Lymphocyte
Macrophage
Mast cell
Mononuclear cell
NKT cells
Null
Other
P815-Mast cell
PBMC
Plasma cell
RMA-lymphocyte
Splenocyte
T cell
T cell CD3-
T cell CD3+
T cell CD4-
T cell CD4+
T cell CD8-
T cell CD8-/CD4-
T cell CD8+
T cell hybridoma
T cell γδ
T2 cells-Lymphoblast
Unknown/Unspecified
Origin
Direct Ex Vivo
Short Term Restimulated
Cell Line / Clone
Cell Line / Clone (EBV transformed, B-LCL)
Cell Line / Clone (Hybridoma)
Blast Activated
In Vivo
Other / Unknown
Antigen Details
Antigen Evidence Code
Representative selection
Author provided Identifier
Exact match to reference information
Imperfect match
Internal Identifier-no external match available
Not determined
Antigen Reference Name
Antigen Containing Object
Type
Source Molecule
Source Organism
Object Type
Molecule Name
Discontinuous Residues
Peptide Sequence
Modified Residue(s)
Modification(s)
1,2-dimethylpropylamine
2-aminoisobutiric acid
4-azidobenzoic acid (ABA)
Acetylation|ACET
Amidation|AMID
Biotin|BIOT
Citrullination|CITR
Cysteinylation
D-aminoacid
Deamidation followed by a methylation|DEAME
Deamidation|DEAM
Fluorenylmethyloxycarbonyl
Formylation|FORM
Galactosylation
Glucosylation (Glycation)|GLUC
Glycosylation
I/L uncertainty
iodo-4-azidosalicylic acid (IASA)
Hydroxylation
Hydroxylation and Galactosylation
Hydroxylation, Glucosylation, and Galactosylation
Main chain modification
Methylation|METH
Myristoylation|MYRI
N-acetylation
Nitration
Norleucine substitution
Oxidation
Palmitoylation|PALM
Phosphorylation|PHOS
Pyrrolidone carboxylic acid (Glu)|PYRE
Reduction
S-acetylmercaptoacetyl
Stereoisomer
Chain 1 Name
Molecule Accession
Source Organism
Modified Residue(s)
Modification(s)
1,2-dimethylpropylamine
2-aminoisobutiric acid
4-azidobenzoic acid (ABA)
Acetylation|ACET
Amidation|AMID
Biotin|BIOT
Citrullination|CITR
Cysteinylation
D-aminoacid
Deamidation followed by a methylation|DEAME
Deamidation|DEAM
Fluorenylmethyloxycarbonyl
Formylation|FORM
Galactosylation
Glucosylation (Glycation)|GLUC
Glycosylation
I/L uncertainty
iodo-4-azidosalicylic acid (IASA)
Hydroxylation
Hydroxylation and Galactosylation
Hydroxylation, Glucosylation, and Galactosylation
Main chain modification
Methylation|METH
Myristoylation|MYRI
N-acetylation
Nitration
Norleucine substitution
Oxidation
Palmitoylation|PALM
Phosphorylation|PHOS
Pyrrolidone carboxylic acid (Glu)|PYRE
Reduction
S-acetylmercaptoacetyl
Stereoisomer
Chain 2 Name
Chain 2 Accession
Source Organism
Starting Position
Equal To
After
Before
Between
And
Starting Position
Equal To
After
Before
Between
And
Tissue Type
BAL (bronchoalveolar lavage)
Blood
Bone Marrow
Breast
CNS (central nervous system)
CSF (cerebrospinal fluid)
Embryo
Eye
Gastrointestinal Tract
Heart
Kidney
Liver
Lung
Lymph Node
Lymphoid
Other
Pancreas
Peritoneal Fluid
Salivary Gland
Skin
Spleen
Synovial Fluid
Thymus
Umbilical Cord Blood
Derivative Type
Egg
Fruit/Vegetable
Gluten
Latex
Meat
Milk
Nut
Peanut
Pollen
Seed
Unspecified food product
Venom
Cell Type
293-T-Epithelial cell
Adherent cell
B cell
Basophil
C1R cells-B cell
Dendritic cell
EL-4 cells-Lymphoblast
Epithelial cell
Fibroblast
HeLa cells-Epithelial cell
Hepatocyte
JAWS II-dendritic cell
Jurkat-T cell
JY cells-B cell
L cells-Fibroblast
Lymph node cells
Lymphoblast
Lymphocyte
Macrophage
Mast cell
Mononuclear cell
NKT cells
Null
Other
P815-Mast cell
PBMC
Plasma cell
RMA-lymphocyte
Splenocyte
T cell
T cell CD3-
T cell CD3+
T cell CD4-
T cell CD4+
T cell CD8-
T cell CD8-/CD4-
T cell CD8+
T cell hybridoma
T cell γδ
T2 cells-Lymphoblast
Unknown/Unspecified
Origin
Direct Ex Vivo
Short Term Restimulated
Cell Line / Clone
Cell Line / Clone (EBV transformed, B-LCL)
Cell Line / Clone (Hybridoma)
Blast Activated
In Vivo
Other / Unknown
3D Structure of Complex
MHC Chain 1 PDB Chain
MHC Chain 2 PDB Chain
TCR Chain 1 PDB Chain
TCR Chain 2 PDB Chain
Epitope PDB Chain
Epitope Residues
Viewer Flag
Any
Yes
No
Comments
Curated Contacts
Epitope Residues
Epitope Residues Interacting with MHC
Epitope Residues Interacting with TCR
MHC Residues Interacting with Epitope
MHC Residues Interacting with TCR
TCR Residues Interacting with Epitope
TCR Residues Interacting with MHC
Contact Area for Epitope-MHC
Equal To
Above
Below
Between
And
Contact Area for TCR
Equal To
Above
Below
Between
And
Calculated Contacts
Epitope Residues Interacting with MHC
Epitope Residues Interacting with TCR
MHC Residues Interacting with Epitope
MHC Residues Interacting with TCR
TCR Residues Interacting with Epitope
TCR Residues Interacting with MHC
Contact Area for Epitope-MHC
Equal To
Above
Below
Between
And
Contact Area for TCR
Equal To
Above
Below
Between
And
Assay Reference Details
Assay Comments
Location of Assay Data in Reference